Dr. Reddy’s Laboratories Ltd is a leading India-based pharamceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations.
Financial Results:
Dr Reddy’s Laboratories Ltd reported Revenues for Q1FY24 of ₹6,758.00 Crores up from ₹5,233.00 Crore year on year, a rise of 29.14%.
Total Expenses for Q1FY24 of ₹5,086.00 Crores up from ₹4,629.00 Crores year on year, a rise of 9.87%.
Consolidated Net Profit of ₹1,405.00 Crores up 18.17% from ₹1,189.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹84.36, up 18.09% from ₹71.44 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.